By Scott Graham | November 30, 2021
Gilliland brings a wealth of trial experience in patent cases and other civil litigation that positions him to be an effective problem-solver. Most all of his work has been for plaintiffs, which might play into perceptions about Albright's courtroom.
By Scott Graham | November 29, 2021
The Senate Judiciary Committee is expected to hold a hearing on her nomination Wednesday. Patent eligibility, the Patent Trial and Appeal Board and pharmaceutical patents are likely to be hot topics.
By ALM Staff | November 26, 2021
This suit was surfaced by Law.com Radar. Read the complaint here.
By Ross Todd | November 23, 2021
Barbara Mullin of Patterson Belknap Webb & Tyler fended off a generic drug maker's patent challenge to Janssen's antipsychotic drug Invega Sustenna. The win means nearly 10 more years of patent protection for the drug.
New York Law Journal | Analysis
By Rob Maier | November 19, 2021
The Federal Circuit's precedential decision earlier this month in 'Celgene v. Mylan Pharmaceuticals', No. 20-1154 (Fed. Cir. Nov. 5, 2021) provided further guidance regarding what constitutes an act of infringement for venue purposes in the ANDA context.
By Ross Todd | November 19, 2021
Barbara Mullin of Patterson Belknap Webb & Tyler fended off a generic drug maker's patent challenge to Janssen's antipsychotic drug Invega Sustenna which has more than $1.5 billion in annual sales. The win means nearly 10 more years of patent protection for the drug.
By ALM Staff | November 19, 2021
This suit was surfaced by Law.com Radar. Read the complaint here.
By Danielle Williams and Tom Melsheimer | November 17, 2021
The Eastern and Western districts have successfully moved their dockets forward, have resumed nearly a typical trial schedule, and are serving as examples of the strength of our civil jury system.
By Scott Graham | November 16, 2021
Six weeks after The Wall Street Journal highlighted the judge's apparent conflicts of interest, Gilstrap told Target through the court's clerk that his wife's trust no longer owns the company's stock, and that it has not influenced his decision making. The judge said he intends to keep presiding, but will listen to objections.
By Scott Graham | November 16, 2021
A previous suit had foundered on patent eligibility issues. This time Shore Chan got the case to a jury before U.S. District Judge Alan Albright.
Presented by BigVoodoo
Consulting Magazine identifies the best firms to work for in the consulting profession.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Women, Influence & Power in Law Awards honors women lawyers who have made a remarkable difference in the legal profession.
The Los Angeles office of Epstein Becker & Green is seeking a partner-level attorney to work in its growing national management-side Emp...
Note: This position is hybrid, however, it is discretionary, and the office location is in Bradenton, Florida.Note: The salary range reflect...
Litigation defense commercial casualty/complex catastrophic cases. Flexible schedule with work in Philadelphia, Conshohocken, and/or remot...